{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T23:59:02Z","timestamp":1770335942947,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,11,18]],"date-time":"2014-11-18T00:00:00Z","timestamp":1416268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s40257-014-0101-9","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T13:43:33Z","timestamp":1416577413000},"page":"503-515","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Treatment of Pemphigus Vulgaris and Pemphigus Foliaceus: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"15","author":[{"given":"Lihi","family":"Atzmony","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmilia","family":"Hodak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gdalevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer","family":"Rosenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Mimouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,18]]},"reference":[{"key":"101_CR1","first-page":"461","volume-title":"Dermatology","author":"Amagai M Pemphigus","year":"2012","unstructured":"Pemphigus Amagai M. In: Bolognia JL, Jorizzo JL, Schaffer JV, editors. Dermatology. 3rd ed. London: Mosby Elsevier; 2012. p. 461\u201374.","edition":"3"},{"key":"101_CR2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archderm.1996.03890260105016","volume":"132","author":"JC Bystryn","year":"1996","unstructured":"Bystryn JC, Steinman NM. The adjuvant therapy of pemphigus. An update. Arch Dermatol. 1996;132:203\u201312 (Review).","journal-title":"Arch Dermatol"},{"key":"101_CR3","first-page":"100","volume":"144","author":"LK Martin","year":"2008","unstructured":"Martin LK, Murrell DF. Treatment of pemphigus: the need for more evidence. Arch Dermatol. 2008;144:100\u20131.","journal-title":"Arch Dermatol"},{"key":"101_CR4","first-page":"CD006263","volume":"1","author":"LK Martin","year":"2009","unstructured":"Martin LK, Agero AL, Werth V, Villanueva E, Segall J, et al. Interventions for pemphigus vulgaris and pemphigus foliaceus. Cochrane Database Syst Rev. 2009;1:CD006263.","journal-title":"Cochrane Database Syst Rev"},{"key":"101_CR5","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.","journal-title":"PLoS Med"},{"key":"101_CR6","unstructured":"Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions, Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. 2011. http:\/\/www.cochrane-handbook.org . Accessed 20 Aug 2014."},{"key":"101_CR7","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaad.2008.01.012","volume":"58","author":"DF Murrell","year":"2008","unstructured":"Murrell DF, Dick S, Ahmed AR, Amagai M, Barnadas MA, et al. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol. 2008;58:1043\u20136.","journal-title":"J Am Acad Dermatol"},{"key":"101_CR8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-4362.1990.tb04765.x","volume":"29","author":"KV Ratnam","year":"1990","unstructured":"Ratnam KV, Phay KL, Tan CK. Pemphigus therapy with oral prednisolone regimens. A 5-year study. Int J Dermatol. 1990;29:363\u20137.","journal-title":"Int J Dermatol"},{"key":"101_CR9","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/archderm.142.5.570","volume":"142","author":"LF Mentink","year":"2006","unstructured":"Mentink LF, Mackenzie MW, T\u00f3th GG, Laseur M, Lambert FP, et al. Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial. Arch Dermatol. 2006;142:570\u20136.","journal-title":"Arch Dermatol"},{"key":"101_CR10","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaad.2007.05.024","volume":"57","author":"C Chams-Davatchi","year":"2007","unstructured":"Chams-Davatchi C, Esmaili N, Daneshpazhooh M, Valikhani M, Balighi K, et al. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris. J Am Acad Dermatol. 2007;57:622\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"101_CR11","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1468-3083.2012.04717.x","volume":"27","author":"C Chams-Davatchi","year":"2013","unstructured":"Chams-Davatchi C, Mortazavizadeh A, Daneshpazhooh M, Davatchi F, Balighi K, et al. Randomized double blind trial of prednisolone and azathioprine, vs. prednisolone and placebo, in the treatment of pemphigus vulgaris. J Eur Acad Dermatol Venereol. 2013;27:1285\u201392.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"101_CR12","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1468-3083.2011.04170.x","volume":"26","author":"D Ioannides","year":"2012","unstructured":"Ioannides D, Apalla Z, Lazaridou E, Rigopoulos D. Evaluation of mycophenolate mofetil as a steroid-sparing agent in pemphigus: a randomized, prospective study. J Eur Acad Dermatol Venereol. 2012;26:855\u201360.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"101_CR13","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/jid.2010.91","volume":"130","author":"S Beissert","year":"2010","unstructured":"Beissert S, Mimouni D, Kanwar AJ, Solomons N, Kalia V, et al. Treating pemphigus vulgaris with prednisone and mycophenolatemofetil: a multicenter, randomized, placebo-controlled trial. J Invest Dermatol. 2010;130:2041\u20138.","journal-title":"J Invest Dermatol"},{"key":"101_CR14","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-4362.1994.tb01003.x","volume":"33","author":"F Chrysomallis","year":"1994","unstructured":"Chrysomallis F, Ioannides D, Teknetzis A, Panagiotidou D, Minas A. Treatment of oral pemphigus vulgaris. Int J Dermatol. 1994;33:803\u20137.","journal-title":"Int J Dermatol"},{"key":"101_CR15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/ced.12073","volume":"38","author":"VK Sharma","year":"2013","unstructured":"Sharma VK, Khandpur S. Evaluation of cyclophosphamide pulse therapy as an adjuvant to oral corticosteroid in the management of pemphigus vulgaris. Clin Exp Dermatol. 2013;38:659\u201364.","journal-title":"Clin Exp Dermatol"},{"key":"101_CR16","first-page":"868","volume":"136","author":"D Ioannides","year":"2000","unstructured":"Ioannides D, Chrysomallis F, Bystryn JC. Ineffectiveness of cyclosporine as an adjuvant to corticosteroids in the treatment of pemphigus. Arch Dermatol. 2000;136:868\u201372.","journal-title":"Arch Dermatol"},{"key":"101_CR17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaad.2008.09.052","volume":"60","author":"M Amagai","year":"2009","unstructured":"Amagai M, Ikeda S, Shimizu H, Iizuka H, Hanada K, Pemphigus Study Group, et al. A randomized double-blind trial of intravenous immunoglobulin for pemphigus. J Am Acad Dermatol. 2009;60:595\u2013603.","journal-title":"J Am Acad Dermatol"},{"key":"101_CR18","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/archderm.1988.01670110019004","volume":"124","author":"JC Guillaume","year":"1988","unstructured":"Guillaume JC, Roujeau JC, Morel P, Doutre MS, Guillot B, et al. Controlled study of plasma exchange in pemphigus. Arch Dermatol. 1988;124:1659\u201363.","journal-title":"Arch Dermatol"},{"key":"101_CR19","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archderm.142.11.1447","volume":"142","author":"S Beissert","year":"2006","unstructured":"Beissert S, Werfel T, Frieling U, B\u00f6hm M, Sticherling M, et al. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus. Arch Dermatol. 2006;142:1447\u201354.","journal-title":"Arch Dermatol"},{"key":"101_CR20","doi-asserted-by":"crossref","unstructured":"Dastgheib L, Sadati MS, Baghernejhad M. Assessment of the adjuvant effect of tacrolimus in the management of pemphigus vulgaris: a randomized controlled trial. J Dermatolog Treat. 2014 Feb 20. [Epub ahead of print].","DOI":"10.3109\/09546634.2013.873763"},{"key":"101_CR21","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1610-0378.2005.04747.x","volume":"3","author":"E Rose","year":"2005","unstructured":"Rose E, Wever S, Zilliken D, Linse R, Haustein UF, et al. Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study. J Dtsch Dermatol Ges. 2005;3:200\u20136.","journal-title":"J Dtsch Dermatol Ges"},{"key":"101_CR22","doi-asserted-by":"crossref","first-page":"476","DOI":"10.4103\/0378-6323.55390","volume":"75","author":"PK Sethy","year":"2009","unstructured":"Sethy PK, Khandpur S, Sharma VK. Randomized open comparative trial of dexamethasone-cyclophosphamide pulse and daily oral cyclophosphamide versus cyclophosphamide pulse and daily oral prednisolone in pemphigus vulgaris. Indian J Dermatol Venereol Leprol. 2009;75:476\u201382.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"101_CR23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/0378-6323.104672","volume":"79","author":"NV Parmar","year":"2013","unstructured":"Parmar NV, Kanwar AJ, Minz RW, Parsad D, Vinay K, et al. Assessment of the therapeutic benefit of dexamethasone cyclophosphamide pulse versus only oral cyclophosphamide in phase II of the dexamethasone cyclophosphamide pulse therapy: a preliminary prospective randomized controlled study. Indian J Dermatol Venereol Leprol. 2013;79:70\u20136.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"101_CR24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.144.1.25","volume":"144","author":"VP Werth","year":"2008","unstructured":"Werth VP, Fivenson D, Pandya AG, Chen D, Rico MJ, et al. Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris. Arch Dermatol. 2008;144:25\u201332.","journal-title":"Arch Dermatol"},{"key":"101_CR25","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/bjd.12972","volume":"170","author":"AJ Kanwar","year":"2014","unstructured":"Kanwar AJ, Vinay K, Sawatkar GU, Dogra S, Minz RW, et al. Clinical and immunological outcomes of high and low dose rituximab treatments in pemphigus patients: a randomized comparative observer blinded study. Br J Dermatol. 2014;170:1341\u20139.","journal-title":"Br J Dermatol"},{"key":"101_CR26","first-page":"976","volume":"18","author":"F Iraji","year":"2013","unstructured":"Iraji F, Faghihi G, Siadat AH. The efficacy of acyclovir in treatment of the pemphigus vulgaris. J Res Med Sci. 2013;18:976\u20138.","journal-title":"J Res Med Sci"},{"key":"101_CR27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1468-3083.2006.01873.x","volume":"21","author":"MN Tabrizi","year":"2007","unstructured":"Tabrizi MN, Chams-Davatchi C, Esmaeeli N, Noormohammadpoor P, Safar F, et al. Accelerating effects of epidermal growth factor on skin lesions of pemphigus vulgaris: a double-blind, randomized, controlled trial. J Eur Acad Dermatol Venereol. 2007;21:79\u201384.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"101_CR28","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/archderm.139.8.1051","volume":"139","author":"AR Ahmed","year":"2003","unstructured":"Ahmed AR, Dahl MV. Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases. Arch Dermatol. 2003;139:1051\u20139.","journal-title":"Arch Dermatol"},{"key":"101_CR29","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1067\/mjd.2002.126273","volume":"47","author":"TG Salopek","year":"2002","unstructured":"Salopek TG, Logsetty S, Tredget EE. Anti-CD20 chimeric monoclonal antibody (rituximab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris with implications in the pathogenesis of the disorder. J Am Acad Dermatol. 2002;47:785\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"101_CR30","doi-asserted-by":"crossref","unstructured":"Heelan K, Al-Mohammedi F, Smith MJ, Knowles S, Lansang P, et al. Durable remission of pemphigus with a fixed-dose rituximab protocol. JAMA Dermatol. 2014 Feb 5. doi: 10.1001\/jamadermatol.2013.6739 . [Epub ahead of print].","DOI":"10.1001\/jamadermatol.2013.6739"},{"key":"101_CR31","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jaad.2012.08.010","volume":"68","author":"YA Leshem","year":"2013","unstructured":"Leshem YA, Hodak E, David M, Anhalt GJ, Mimouni D. Successful treatment of pemphigus with biweekly 1-g infusions of rituximab: a retrospective study of 47 patients. J Am Acad Dermatol. 2013;68:404\u201311.","journal-title":"J Am Acad Dermatol"},{"key":"101_CR32","unstructured":"University Hospital, Rouen; Comparison between monoclonal antibody CD20 treatment (Rituximab (mabth\u00e9ra))and general corticotherapy treatment in patients with pemphigus. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000. https:\/\/clinicaltrials.gov\/show\/NCT00784589 . NLM Identifier: NCT00784589. Accessed 3 Aug 2014."},{"key":"101_CR33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1590\/S0036-46652001000100007","volume":"43","author":"NC Fernandes","year":"2001","unstructured":"Fernandes NC, Perez M. Treatment of pemphigus vulgaris and pemphigus foliaceus: experience with 71 patients over a 20\u00a0year period. Rev Inst Med Trop Sao Paulo. 2001;43:33\u20136.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"101_CR34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1468-3083.2002.00461.x","volume":"16","author":"F Femiano","year":"2002","unstructured":"Femiano F, Gombos F, Scully C. Pemphigus vulgaris with oral involvement: evaluation of two different systemic corticosteroid therapeutic protocols. J Eur Acad Dermatol Venereol. 2002;16:353\u20136.","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-014-0101-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-014-0101-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-014-0101-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T06:58:42Z","timestamp":1717570722000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-014-0101-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,18]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["101"],"URL":"https:\/\/doi.org\/10.1007\/s40257-014-0101-9","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,18]]}}}